Filing Details
Bone Biologics Corp (NASDAQ:BBLG) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 26, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:BBLG
Bone Biologics Corp (BBLG) Files Quarterly Report for Q0
Bone Biologics Corp (NASDAQ:BBLG) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 26, 2026.
At publication ·
What changed
Bone Biologics Corp (NASDAQ:BBLG) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Bone Biologics Corp filed its Q0 quarterly report (Form 10-Q) with the SEC on October 26, 2026.
- The company's stock trades at $0.38 per share with a market capitalization of $3.4 million.
- The 10-Q contains unaudited financial statements and management commentary on business performance and emerging risks.
Market Context
Bone Biologics Corp's stock currently trades at $0.38 with a market capitalization of $3.4M.
The 10-Q provides Bone Biologics Corp's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Bone Biologics Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BBLG Stock Page
Frequently Asked Questions
Where can I read BBLG's SEC filings?
Browse all filings on our BBLG SEC filings page.
What types of SEC filings does Bone Biologics Corp file?
Public companies like Bone Biologics Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
